Refractory Immune Checkpoint Inhibitor-induced Colitis Improved by Fecal Microbiota Transplantation: A Case Report
Authors:
- 9 November 2021
- journal article
- letter
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 28 (3) , e43-e44
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- British Society of Gastroenterology endorsed guidance for the management of immune checkpoint inhibitor-induced enterocolitisThe Lancet Gastroenterology & Hepatology, 2020
- Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working GroupJournal for ImmunoTherapy of Cancer, 2017
- Nivolumab in Previously Untreated Melanoma withoutBRAFMutationNew England Journal of Medicine, 2015
- Improved Survival with Ipilimumab in Patients with Metastatic MelanomaNew England Journal of Medicine, 2010